University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Hackshaw, A"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 5.

Article

Wardle, J, von Wagner, C, Kralj-Hans, I, Halloran, SP, Smith, SG, McGregor, LM, Vart, G, Howe, R, Snowball, J, Handley, G, Logan, RF, Rainbow, S, Smith, S, Thomas, MC, Counsell, N, Morris, S, Duffy, SW, Hackshaw, A, Moss, S, Atkin, W and Raine, R (2016) Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials LANCET, 387 (10020). pp. 751-759.

Raine, R, Duffy, SW, Wardle, J, Solmi, F, Morris, S, Howe, R, Kralj-Hans, I, Snowball, J, Counsell, N, Moss, S, Hackshaw, A, von Wagner, C, Vart, G, McGregor, L, Smith, SG, Halloran, S, Handley, G, Logan, RF, Rainbow, S, Smith, S, Thomas, MC and Atkin, W (2016) Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening BRITISH JOURNAL OF CANCER, 114 (3). pp. 321-326.

McGregor, LM, von Wagner, C, Atkin, W, Kralj-Hans, I, Halloran, SP, Handley, G, Logan, RF, Rainbow, S, Smith, S, Snowball, J, Thomas, MC, Smith, SG, Vart, G, Howe, R, Counsell, N, Hackshaw, A, Morris, S, Duffy, SW, Raine, R and Wardle, J (2016) Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised Trial GASTROENTEROLOGY RESEARCH AND PRACTICE, ARTN 36701.

Jamal-Hanjan, M, Hackshaw, A, Ngai, Y, Shaw, J, Dive, C, Quezada, S, Middleton, G, de Bruin, E, Le Quesne, J, Shafi, Shahida, Falzon, M, Horswell, S, Blackhall, F, Khan, I, Janes, S, Nicolson, M, Lawrence, D, Forster, M, Fennell, D, Lee, SM, Lester, J, Kerr, K, Muller, Sheila, Iles, N, Smith, S, Murugaesu, N, Mitter, R, Salm, M, Stuart, A, Matthews, N, Adams, H, Ahmad, T, Attanoos, R, Bennett, J, Birkbak, NJ, Booton, R, Brady, G, Buchan, K, Capitano, A, Chetty, M, Cobbold, M, Crosbie, P, Davies, Hilary, Denison, A, Djearman, M, Goldman, J, Haswell, T, Joseph, L, Kornaszewska, M, Krebs, M, Langman, G, MacKenzie, M, Millar, J, Morgan, B, Naidu, B, Nonaka, D, Peggs, K, Pritchard, K, Remmen, H, Rowan, A, Shah, R, Smith, Eleanor, Summers, Y, Taylor, M, Veeriah, S, Waller, D, Wilcox, B, Wilcox, M, Woolhouse, I, McGranahan, N and Swanton, C (2014) Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study PLoS Biology, 12 (7), e1001906. pp. 1-7.

Lee, SM, Khan, I, Upadhyay, S, Lewanski, C, Falk, S, Skailes, G, Marshall, E, Woll, PJ, Hatton, M, Lal, R, Jones, R, Toy, E, Chao, D, Middleton, G, Bulley, S, Ngai, Y, Rudd, R, Hackshaw, A and Boshoff, C (2012) First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial LANCET ONCOLOGY, 13 (11). pp. 1161-1170.

This list was generated on Tue Sep 26 14:49:20 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800